Philippe LF

Senior executive with over 25yrs experience in pharma - All opinions expressed here are my own

[Peter Kolchinsky @PeterKolchinsky]

Once again patients & biotech face the threat of misguided policy. Please read & sign on to this letter urging Senate not to discourage small molecule drugs in favor of injectable biologics. As before, we need hundreds of leaders to stand together. https://t.co/FiWqgKCjk8

[Philippe LF @Ph_LopesF]

@ArtKrieg @Regeneron Congratulations Art for finalizing the deal while running the marathon 😀👍🏻

[Philippe LF @Ph_LopesF]

Great to join you @LifeSciVC and this fantastic group of pharma and biotech executives to raise money for such worthwhile causes. A great mix of fun, hilly runs, lack of sleep and bad smell. #RTB2021 #runnersdrugsmoney @IpsenGroup

[Bruce Booth @LifeSciVC]

We did it! Reach The Beach 2021. Great group, superb runs, wonderful weather lots of fun. And raised over $207K for charity thx to an awesome extended team! @RagnarRelay #RTB2021 #RunnersDrugsMoney

[Philippe LF @Ph_LopesF]

@ArtKrieg @Mark_Tebbe Foggy indeed ! 😀

[Philippe LF @Ph_LopesF]

@Ptipirneni Definitely the best medicine, for body and mind !!!

[Philippe LF @Ph_LopesF]

@NelloMainolfi Welcome back. Let’s run together soon 🏃‍♂️

[Philippe LF @Ph_LopesF]

@Ptipirneni 😂

[Wendell Potter @wendellpotter]

Over the last few days, I’ve been asked many times: If a new Supreme Court overturns Obamacare, what would that mean for most Americans? As a former health insurance executive, here’s the scary truth: (1/12)

[Philippe LF @Ph_LopesF]

Great webinar by @ArtKrieg on oligonucleotide therapies and great interview by Luke @ldtimmerman as part of his superb coverage of the pandemic ! https://t.co/N6KNd80HHe

[Luke Timmerman @ldtimmerman]

Webinar by @ArtKrieg on oligonucleotide therapies for COVID-19. One short, accessible version for lay audiences and a longer, more technical version for scientists. Nicely done! https://t.co/9uKU0tKHsb

[Philippe LF @Ph_LopesF]

Very interesting article from Otello on the COVID19. Thanks Luke for sharing.

[Luke Timmerman @ldtimmerman]

Lessons from Italy: Guest editorial by Otello Stampacchia @OtelloVC on the urgent #COVID19 threat and the types of responses needed ASAP. (Free, shareable article). https://t.co/HoFUVki1cr

[Philippe LF @Ph_LopesF]

Superb analysis of the pricing situation by @LifeSciVC. And clear path to a better outcome through capping out-of-pocket costs and better transparency of healthcare money flows. A must read.

[Bruce Booth @LifeSciVC]

Venturing A Perspective On The Drug Pricing Debate.

I've been largely quiet on this topic, but couldn't any longer. First principles of investin and what it means for pricing. Observations on the US system. And a few suggestions for policy emphasis.

https://t.co/750EeNN6tI

[Philippe LF @Ph_LopesF]

@NelloMainolfi Congratulations Nello !

[Philippe LF @Ph_LopesF]

Another fun weekend running #RTB2019 with friends from @atlasventure and others from the pharma and biotech community. Pushing hard and not sleeping much. And we raised together over $120,000 for various charities. My contribution goes as every year for the @ocularmelanoma .

[Atlas Venture @atlasventure]

And they’re off! Good luck to #RunnersDrugsandMoney at #RTB19! And to our biotech brethren teams #Nimbeaches, @Ptipirneni #MorphicTx team, and all the #AtlasShrugged teams! Have a blast, and remember - more cowbell!

[Philippe LF @Ph_LopesF]

Great article indeed on US drug pricing. “Four of this year’s Fortune 10 companies — UnitedHealth Group, McKesson, CVS Health, and AmerisourceBergen — are middlemen in the U.S. drug distribution system. [...] why is their revenue higher than GE, Google, and Verizon’s?“

[Jeb Keiper @JebKeiper]

Very well written piece by Paul Hastings on US drug pricing, PBMs, and patient access in @statnews. Worth the read and the r/t.

[Philippe LF @Ph_LopesF]

@ldtimmerman @climbtofight @fredhutch Congratulations @ldtimmerman and all for the raising 50% more than the initial plan and for the nice challenge. Special thoughts to Sandy, Bill, Zoe and others that engaged strongly in this @climbtofight !

[Philippe LF @Ph_LopesF]

@VasNarasimhan @CNBC @Novartis @cnbcevents When a surgeon saves a life, will he / she receive yearly payments for the the life of his patient?

[Philippe LF @Ph_LopesF]

We have entered a new strategic alliance with @GSK to jointly develop and commercialize our investigational bifunctional #immunotherapy for #cancer. (link: https://t.co/czc6USSyjB) https://t.co/7FEfAUlhVa

[Philippe LF @Ph_LopesF]

Interesting analysis of the cost of drug development.
Guest column: The real cost of drug development - https://t.co/WPfdUxFtFe

[Philippe LF @Ph_LopesF]

Very interesting animation, showing the difference between reality, perception and media attention in healthcare related topics. https://t.co/jbJEe7sS4G

[Isaac Kohane @zakkohane]

Worth staring at for at least 5 minutes CC @ashishkjha https://t.co/TUhZVmdlta

[Philippe LF @Ph_LopesF]

The European Commission has approved MAVENCLAD® (Cladribine Tablets) for the treatment of highly active RMS in Europe!